Diebold Nixdorf, Incorporated
DBD · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2,115,813 | $2,060,880 | $1,643,872 | $1,618,304 |
| - Cash | $262,600 | $295,200 | $306,500 | $296,200 |
| + Debt | $934,000 | $1,063,000 | $1,055,130 | $1,047,100 |
| Enterprise Value | $2,787,213 | $2,828,680 | $2,392,502 | $2,369,204 |
| Revenue | $945,200 | $915,200 | $841,100 | $988,900 |
| % Growth | 3.3% | 8.8% | -14.9% | – |
| Gross Profit | $247,900 | $234,000 | $202,400 | $236,400 |
| % Margin | 26.2% | 25.6% | 24.1% | 23.9% |
| EBITDA | $104,800 | $70,200 | $48,000 | $132,400 |
| % Margin | 11.1% | 7.7% | 5.7% | 13.4% |
| Net Income | $41,100 | $12,200 | -$8,300 | $5,600 |
| % Margin | 4.3% | 1.3% | -1% | 0.6% |
| EPS Diluted | 1.09 | 0.33 | -0.22 | 0.15 |
| % Growth | 230.3% | 250% | -246.7% | – |
| Operating Cash Flow | $37,400 | $30,100 | $15,700 | $196,200 |
| Capital Expenditures | -$12,900 | -$17,400 | -$9,600 | -$10,000 |
| Free Cash Flow | $24,500 | $12,700 | $6,100 | $186,200 |